Maria Pia Morelli, Rafet Basar, David Marin, Brittany E. Zeller, Jason Willis, Bryan K. Kee, Sophia Jacob, Stacy Diao, Ryan W. Huey, Van K. Morris, Alisha Heather Bent, S. Daniel Haldar, Amina Nurmammadova, Ritu Bohat, David Menter, Michael J. Overman, Xiling Shen, Scott Kopetz, Elizabeth J. Shpall, Katy Rezvani. "Phase 1 dose escalation and expansion study of TROP2 CAR-engineered IL-15-transduced cord blood-derived NK cells in combination with cetuximab in patients with colorectal cancer (CRC) with minimal residual disease (MRD).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps275